Abstract
Purpose
The assessment of Health-Related Quality of Life (HRQoL) in cancer patients has become increasingly important during the past decades. The aim of this study was to evaluate the HRQoL in patients treated for low-grade glioma (LGG).
Methods and Materials
Forty-three adult patients with LGG were evaluated prospectively between September 2006 and December 2010. We assessed HRQoL at baseline (after surgery before radiotherapy), at the end of radiotherapy and during follow-up (every 3 months for the first 2 years and every 6 months between 2 and 5 years), using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30 (EORTC-C30), Brain Cancer Module-20 (BN-20), Mini Mental State Examination (MMSE) and Hospital Anxiety and Depression Scale (HADS).
Results
We demonstrated changes in global score (p = 0.004), and future uncertainty (p < 0.001), communication deficit (p = 0.007), headache (p < 0.001), drowsiness (p = 0.002) and hair loss (p < 0.001), and recall score (p = 0.0029) during follow-up. All complaints of LGG patients showed improvement, except for the hair loss. Although the baseline cognitive function scores was not significantly different, the third-year cognitive function scores of patients who used antiepileptic drugs had lower when compared to patients who did not use (p < 0.001). The baseline and follow-up anxiety and depression scores did not differ significantly.
Conclusion
Our results suggested that there were improvement in HRQoL in LGG patients during follow-up and antiepileptic drugs had negative effect on cognitive functions.
Similar content being viewed by others
References
Ruiz J, Lesser GJ (2009) Low grade gliomas. Curr Treat Options Oncol 10:231–242
Taphoorn MJ (2003) Neurocognitive sequelae in the treatment of low grade gliomas. Semin Oncol 30:45–48
Pace A, Bove L, Innocenti P et al (1998) Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res 17:479–482
Tucha O, Smely C, Preier M et al (2003) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333
Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618–626
Efficace F, Bottomley A (2002) Health-related quality of life assessment methodology and reported outcomes in randomized controlled trials of primary brain cancer. Eur J Cancer 38:1824–1831
Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolbers JG, Karim ABMF (1992) Assessment of quality of life in patients treated for low grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372–376
Najman JM, Levive S (1981) Evaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med 15F:105–115
Haes JCM, Knippenberg FE (1985) The quality of life of cancer patients. A review of the literature. Soc Sci Med 20:809–817
Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology (Williston Park) 2:69–76
Weitzner M, Meyers CA (1997) Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 6:169–177
Browne JP, O’Boyle CA, McGee HM, Joyce CR, McDonald NJ, O’Malley K, Hiltbrunner B (1994) Individual quality of life in the healthy elderly. Qual Life Res 3:235–244
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432
Osoba D, Brada M, Prados MD, Yung WKA (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol 2:221–228
Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer in clinical trials. Recent Result Cancer Res 111:231–249
Bellamy N (2003) Principles of outcome assessment. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, Toronto, pp 21–30
Taphoorn MJ, Van den Bent MJ, Mauer MEL, Coens C, Delattre JY et al (2007) Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for research and treatment of cancer randomized clinical trial. J Clin Oncol 25:5723–5730
Kramer JA, Curan D, Piccart M et al (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36:1498–1506
Velikova G, Booth L, Smith AB et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22:714–724
Montazeri A, Milroy R, Hole D et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31:233–240
Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242
Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade gloima patients. J Clin Oncol 19:4037–4047
Brown PD, Buckner JC, Uhm JH et al (2003) The neurocognitive effects of radiation in adult low grade glioma patients. Neuro Oncol 5:161–167
Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520
Maire JP, Coudin B, Guerin J, Caudry M (1987) Neuropsychological impairment in adults with brain tumors. Am J Clin Oncol 10:156–162
Anderson SW, Damasio H, Tranel D (1990) Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47:397–405
Gregor A, Cull A, Traynor E et al (1996) Neuropsycholometric evaluation of long-term survivors of adult brain tumors: relationship with tumor and treatment parameters. Radiother Oncol 41:55–59
DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796
Garratt A, Schmidt L, Mackintosh A, Fitzpatric R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. Br Med J 15:141–147
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ (1993) The European Organization for Research and Treatment of Cancer EORTC C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curan D, Bottomley A, and on behalf of the EORTC Quality of Life Study Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels, Belgium
Osoba D, Rodrigues G, Myles J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139–144
Folstein MF, Folstein S, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Taphoorn MJB, Schiphorts AK, Snoek FJ et al (1994) Cognitive functions and quality of life in patients with low grade gliomas: the impact of radiotherapy. Ann Neurol 36:48–54
Armstrong C, Ruffer J, Corn B et al (1995) Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 13:2263–2271
Armstrong CL, Hunter JV, Ledakins GE, Cohen B, Tallent EM, Goldstein BH et al (2002) Late cognitive and radiographic changes related to radiotherapy. Initial prospective findings. Neurology 59:40–48
Vigliani MC, Sichez N, Poisson M, Delattre JY (1996) A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 35:527–533
Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, Pyykkönen J, Jaaskelainen J (2001) Adverse long-term effects of brain radiotherapy in adult low grade glioma patients. Neurology 56:1285–1290
Edvardsson T, Ahlsrom G (2005) Illness-related problems and coping among persons with low grade glioma. Psychooncology 14:728–737
Klein M, Heimans JJ, Aaronson NK et al (2002) Effects of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequela in low grade gliomas: a comparative study. Lancet 360:1361–1368
Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumors: a 5-year follow-up study. Neurosurgery 56:1234–1241
Klein M, Engelberts NH, vander Ploeg HM et al (2003) Epilepsy in low grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520
Carpenter WT, Gruen PH (1982) Cortisol’s effect on human mental functioning. J Clin Psychopharmacol 2:91–101
Salander P, Bergenheim T, Henriksson R (1996) The creation of protection and hope in patients with malignant brain tumors. Soc Sci Med 42:985–996
Conflict of interest
None
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yavas, C., Zorlu, F., Ozyigit, G. et al. Prospective assessment of health-related quality of life in patients with low-grade glioma. Support Care Cancer 20, 1859–1868 (2012). https://doi.org/10.1007/s00520-011-1288-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1288-4